LSO Breakfast Series

Member Marathon

June 23

9am - 10am

Back Bay Life Science Advisors

Back Bay Life Science Advisors provides life science strategy and investment banking guidance and execution to global biopharma and medtech companies across every stage and sector.

With offices in Boston, Toronto and Frankfurt, Back Bay guides companies of all sizes on technology and drug development, from planning and initial concept to product commercialization, franchising and licensing, partnering, M&A, divestiture and partnering.

Back Bay teams are comprised of MDs, PhDs, scientific and banking experts with a love for building the next generation of life science breakthroughs. We guide innovators in oncology, cell and gene therapy, cardiology, neuroinflammation, rare disease and more.

View highlights from our portfolio of projects and life science transactions and subscribe to The Life Science Report, our life science industry podcast, at https://www.bblsa.com/podcasts. www.bblsa.com

Bioenterprise: Canada's Food and Agri-Tech Engine

Accelerating innovation through our national and global network, Bioenterprise is Canada’s Food & Agri-Tech Engine bringing together key players in the food and agri-tech ecosystem to support start-ups in their journey from market entry to global expansion. We are committed to connecting entrepreneurs to our network of industry leaders, researchers, government stakeholders, and critical service providers to help ensure their success.

Loyalist College

Ranked one of Canada’s top 50 research colleges, Loyalist College empowers students, faculty, staff, and partners through experiential, industry cluster-based education, training and applied research programs. As Ontario’s Destination College, the College provides job-ready graduates for, and knowledge transfer to, industry and the community.

Located on more than 200 acres in the beautiful Bay of Quinte region, the College is perfectly positioned between Toronto, Ottawa and Montreal and is a key driver of social and economic health in eastern Ontario, contributing $396.3 million annually to the regional economy.

Loyalist College offers more than 70 full-time diploma, certificate and apprenticeship programs in biosciences, building sciences, business, community service, health and wellness, media studies, public safety, and skilled trades. Continuing education options are available through LoyalistFocus.com, including hundreds of online, distance and in-class courses, and through the College’s 100+ university transfer agreements. For more information on Loyalist College’s Belleville, Bancroft and Toronto campuses and Port Hope satellite location, visit loyalistcollege.com.

Xybion Digital

Xybion Digita is a publicly-traded, global SaaS company that helps enterprise life sciences organizations accelerate new drug development into approved medicines that save lives and keep employees safe. Xybion Digital’s low-code technology-based cloud software solutions offer unified end-to-end software platforms for core business processes such as R&D, testing laboratory operations, employee health and workforce safety management with embedded compliance, quality, risk, and enterprise content management systems. Xybion Digital’s end-to-end SaaS model unifies the entire preclinical research and discovery, development, quality, compliance, manufacturing, laboratories, and their employees on a single life sciences cloud platform. Our low code solutions allow clients to rapidly customize Xybion Digital’s extensive library of life sciences, pharmaceutical, healthcare, and revolutionary EHS software systems to easily and seamlessly adapt to client-specific needs. Xybion Digital differentiates itself from legacy systems and modern cloud systems through its unparalleled approach to fully optimizing business processes across entire organizations with a single platform, our patented predictive compliance software, and our ability to adapt our software to meet the exact specifications of all clients.

Our expansive growth began in 2008 when Xybion was acquired by the Banerjee Group, creating an amalgamation of several software companies through strategic acquisitions of Amadeus, Vital Path, and Stelex. In 2021, Xybion transformed into Xybion Digital with our comprehensive, deep industry vertical cloud software as a service platform that replaces several disparate software systems and point solutions with a unified, all-in-one, cloud platform. Xybion Digital is headquartered in Princeton, NJ, with more than 160 customers in 29 countries, and has successfully implemented, supported, and maintained software solutions at several large organizations including US FDA, US Army Medical Research Institute of Infectious Diseases, Pfizer, Novartis, Merck, Abbvie, Biogen, Gilead, Amgen and CROs like Labcorp Drug Development. 100% of the top 20 global biopharmaceutical companies are Xybion Digital’s customers.

Guest Speakers

Jonathan P. Gertler, MD
Co-Founder | Managing Partner & CEO  of Back Bay Life Science Advisors

Jonathan P. Gertler, MD has over 35 years of clinical and scientific experience, and extensive advisory work with biotechnology, medical device, diagnostic, and health care IT companies in both the private and public sectors.

A former vascular surgeon, Dr. Gertler is a frequent speaker and writer on strategic issues facing life science companies at all stages.

He has founded a several life sciences companies, including Antyllus Therapeutics; a development-stage biotechnology company focused on aortic diseases, and Optivio, a commercial-stage enterprise software platform for stress management and performance optimization. Dr. Gertler also founded Cardiovascular Technologies, an endovascular company that successfully exited in 2001.

Throughout his advisory career, Dr. Gertler has counseled companies on growth and liquidity strategies and has been responsible for significant aggregate consideration in M&A private and public equity for biotech, medtech, and HCIT companies. Before his advisory and consulting career and during the latter phases of his academic career, he was a venture partner at SV Life Sciences from 1997-2001.

Dr. Gertler was an academic vascular surgeon, primarily as Associate Professor of Surgery at Harvard Medical School and the Massachusetts General Hospital. He has published extensively in clinical vascular surgery and endothelial and smooth muscle cell biology. He has served as an ad-hoc editor for the Journal of Vascular Surgery, The New England Journal of Medicine, and The Journal of Critical Care Medicine and Surgery.

He currently serves on the Dean’s Advisory Board at Boston University School of Medicine and the Venture Advisory Board of the BioInnovation Institute in Copenhagen. He is a supporter and advisor to several non-profit organizations dedicated to inclusion and diversity, including Life Science Cares and Squashbusters, a sports-based youth development program serving young people in Boston, Lawrence, and Providence.

Dr. Gertler trained in Vascular Surgery at Yale in General Surgery and the Massachusetts General Hospital. He earned a medical degree from Columbia University College of Physicians and Surgeons, an MBA in Health Policy and Management from Boston University, and a BA from Wesleyan University. Dr. Gertler is a Fellow of the American College of Surgeons and a member of numerous academic and clinical surgical societies. He is a Series 24 Registered Securities Principal and is an avid musician, athlete, and fly angler.

Aaron Misener,
Director of Strategic Communications at Bioenterprise

Aaron is Director of Strategic Communications for Bioenterprise Canada, Canada’s Food & Agri-Tech Engine. As the leading national agricultural accelerator, Bioenterprise Canada delivers a significant impact on Canada’s economy by supporting innovative, high-growth businesses with programs and mentorship that match their potential. Aaron utilizes a background in marketing and professional writing to source and secures new revenue streams and funding opportunities, ensure that the organization’s core messaging and mandates remain consistent, and maintain government relations. Aaron acts as an advisor and editor for marketing content related to Bioenterprise Canada and advises on event partnership and sponsorship globally.

Aaron began at Bioenterprise Canada as a Communications and Special Projects Analyst before moving to a management role in marketing, and finally moving to a strategic position as Director. Prior to working in the public sphere, he managed marketing and social portfolios for web-based tech start-ups and maintained a large base of client projects in the education technology sector. Aaron graduated with an M.A. from McMaster University and is a published academic and poet.

Jeremy Laurin,
Senior Vice President, External Relations and Business Development, Loyalist College

Jeremy Laurin is the Senior Vice President, External Relations and Business Development at Loyalist College in Belleville, ON.

Previously he was the Vice President of Business Development and Partnerships at the Ontario Centres of Excellence, now the Ontario Centre of Innovation (OCI).  There Jeremy led an experienced team of Business Development Managers to all corners of the province to find out what’s needed by industry and explore the halls and labs of academia for the latest innovations breakthroughs. Jeremy and his team helped commercialize innovations, transfer technologies and develop promising talent to grow the Ontario economy.

Prior to OCI, Jeremy was the founding President and CEO of ventureLAB, an innovation hub for Central Ontario and the northern GTA that reaches more than 1.8 million Ontarians.

An entrepreneur at heart, Jeremy founded his first of three technology firms in Kingston, Ont., in 1997. Under his guidance, all three were born global. Jeremy’s responsibilities included opening offices in China, Europe, Japan, Korea, and the United States.

To learn more, please click here.

Dr. Pradip Banerjee,
Chairman & CEO of Xybion Corporation

Dr. Pradip K. Banerjee is Xybion’s Chairman of the Board and Chief Executive Officer. He is the founding managing partner, now retired, of Accenture’s R&D line of business. He is an entrepreneurial senior executive with more than 30 years of in-depth experience in the global life sciences, healthcare, and services industries in operations, strategic management, business development, investments, and new venture creations. Previously, he held several R&D management positions at Abbott, Glaxo Smith Kline, and served as President and CEO of the Science Center in Philadelphia.

To learn more, please click here.